Optimisation of fluorescence guidance during robot-assisted laparoscopic sentinel node biopsy for prostate cancer
- PMID: 25092539
- DOI: 10.1016/j.eururo.2014.07.014
Optimisation of fluorescence guidance during robot-assisted laparoscopic sentinel node biopsy for prostate cancer
Abstract
Background: The hybrid tracer was introduced to complement intraoperative radiotracing towards the sentinel nodes (SNs) with fluorescence guidance.
Objective: Improve in vivo fluorescence-based SN identification for prostate cancer by optimising hybrid tracer preparation, injection technique, and fluorescence imaging hardware.
Design, setting, and participants: Forty patients with a Briganti nomogram-based risk >10% of lymph node (LN) metastases were included. After intraprostatic tracer injection, SN mapping was performed (lymphoscintigraphy and single-photon emission computed tomography with computed tomography (SPECT-CT)). In groups 1 and 2, SNs were pursued intraoperatively using a laparoscopic gamma probe followed by fluorescence imaging (FI). In group 3, SNs were initially located via FI. Compared with group 1, in groups 2 and 3, a new tracer formulation was introduced that had a reduced total injected volume (2.0 ml vs. 3.2 ml) but increased particle concentration. For groups 1 and 2, the Tricam SLII with D-Light C laparoscopic FI (LFI) system was used. In group 3, the LFI system was upgraded to an Image 1 HUB HD with D-Light P system.
Intervention: Hybrid tracer-based SN biopsy, extended pelvic lymph node dissection, and robot-assisted radical prostatectomy.
Outcome measurements and statistical analysis: Number and location of the preoperatively identified SNs, in vivo fluorescence-based SN identification rate, tumour status of SNs and LNs, postoperative complications, and biochemical recurrence (BCR).
Results and limitations: Mean fluorescence-based SN identification improved from 63.7% (group 1) to 85.2% and 93.5% for groups 2 and 3, respectively (p=0.012). No differences in postoperative complications were found. BCR occurred in three pN0 patients.
Conclusions: Stepwise optimisation of the hybrid tracer formulation and the LFI system led to a significant improvement in fluorescence-assisted SN identification. Preoperative SPECT-CT remained essential for guiding intraoperative SN localisation.
Patient summary: Intraoperative fluorescence-based SN visualisation can be improved by enhancing the hybrid tracer formulation and laparoscopic fluorescence imaging system.
Keywords: Fluorescence-guided surgery; Hybrid approach; Hybrid tracer; Image-guided surgery; Prostate cancer; Radio-guided surgery; Sentinel (lymph) node.
Copyright © 2014 European Association of Urology. Published by Elsevier B.V. All rights reserved.
Comment in
-
Prostate cancer: Optimizing fluorescence guidance in sentinel node biopsy.Nat Rev Urol. 2014 Oct;11(10):543. doi: 10.1038/nrurol.2014.217. Epub 2014 Aug 19. Nat Rev Urol. 2014. PMID: 25134831 No abstract available.
-
Sentinel node biopsy for prostate cancer: a useless surgical exercise?Eur Urol. 2014 Dec;66(6):999-1000. doi: 10.1016/j.eururo.2014.08.052. Epub 2014 Sep 6. Eur Urol. 2014. PMID: 25199716 No abstract available.
-
Reply from authors re: Francesco Montorsi, Giorgio Gandaglia. Sentinel node biopsy for prostate cancer: a useless surgical exercise? Eur urol 2014;66:999-1000: Removing nodes that count rather than counting nodes that don't.Eur Urol. 2014 Dec;66(6):1000-1. doi: 10.1016/j.eururo.2014.10.005. Epub 2014 Oct 13. Eur Urol. 2014. PMID: 25440526 No abstract available.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
